WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark BYLOK was filed as Word mark on 02/01/2022 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1658372 |
| Register number | 775869 |
| Countries | 
|
| Base trademark |
No. 775869,
November 24, 2021
|
| Application date | February 1, 2022 |
| Expiration date | February 1, 2032 |
Trademark owner
Lonzastrasse
3930 Visp
CH
3930 Visp
CH
Trademark representatives
Neumarkt 15
8401 Winterthur
CH
goods and services
01
Biochemicals, namely, monoclonal or trimeric antibodies and
derivatives thereof, for in-vivo or in-vitro scientific
research and development to treat cancers, inflammatory
diseases, autoimmune diseases, infectious diseases and
cardiovascular diseases and for use in laboratories,
diagnostics and analytics for scientific or research use
05
Pharmaceutical preparations based on human monoclonal or
trimeric antibodies and derivatives thereof, to treat
cancers, inflammatory diseases, autoimmune diseases,
infectious diseases and cardiovascular diseases, and for
related diagnostic or therapeutic use, and for use in
related assays
09
Computer software for scientific laboratory research and
commercial use for applications with monoclonal or trimeric
antibodies used to treat cancers, inflammatory diseases,
autoimmune diseases, infectious diseases and cardiovascular
diseases
42
Medical and scientific research, protein engineering,
pharmaceutical product development, industrial research and
contract research services, all related to human monoclonal
or trimeric antibodies to treat cancers, inflammatory
diseases, autoimmune diseases, infectious diseases and
cardiovascular diseases; Computer programming for
acquisition and processing of medical data in the context of
medical-scientific research, development and therapy with
monoclonal or trimeric antibodies and their derivatives
45
Legal services related to patent exploitation, namely patent
licensing; licensing of intellectual property in the field
of monoclonal or trimeric antibodies for laboratories,
diagnostics and analytics for scientific or research use
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 3, 2023 | 2023/31 Gaz | KR | Rejection |
| June 22, 2023 | 2023/25 Gaz | SG | Rejection |
| June 8, 2023 | 2023/24 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| April 20, 2023 | 2023/17 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| February 2, 2023 | 2023/5 Gaz | JP | Rejection |
| September 20, 2022 | 2022/38 Gaz | EM | Rejection |
| September 1, 2022 | 2022/35 Gaz | US | Rejection |
| August 3, 2022 | 2022/31 Gaz | GB | Rejection |
| May 23, 2022 | 2022/21 Gaz | IN | Rejection |
| February 1, 2022 | 2022/15 Gaz | CH | Registration |
ID: 141658372